hepatitis C

FDA says highly anticipated Merck drug achieved goal of eliminating traces of hepatitis C
Yahoo/AP
Mon, 04/25/11 - 09:17 am
Merck
FDA
hepatitis C
Boceprevir
Merck, Vertex Prep for Hep C Drug Panels
TheStreet.com
Thu, 04/21/11 - 09:21 am
Merck
Vertex Pharmaceuticals
hepatitis C
FDA
Boceprevir
Telaprevir
advisory panels
Vertex Receives Good News on Hepatitis C Treatment
Seeking Alpha
Thu, 04/14/11 - 11:01 am
Vertex Pharmaceuticals
hepatitis C
Telaprevir
Merck
bacepravir
Victrella
Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
Seeking Alpha
Mon, 04/11/11 - 02:29 pm
hepatitis C
Vertex Pharmaceuticals
Telaprevir
Dendreon
Forest Labs
Orexigen
Biotech Stock Mailbag: Hep C Stock Winners
TheStreet.com
Fri, 04/8/11 - 10:56 am
hepatitis C
Pharmasset
Merck
Optimer
Vertex Pharmaceuticals
Gilead Sciences
JNJ
InterMune
Bristol-Myers Squibb
Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France
Bloomberg
Mon, 04/4/11 - 08:34 am
Merck
JNJ
hepatitis C
France
Vertex Pharmaceuticals
Telaprevir
Boceprevir
Vertex Pharmaceuticals' potential hepatitis C treatment meets safety goal in midstage study
Yahoo/AP
Thu, 03/31/11 - 12:27 pm
hepatitis C
Vertex Pharmaceuticals
VX-222
Pharmasset Hepatitis C Drug Combination Helped 98% of Patients
Bloomberg
Thu, 03/31/11 - 12:25 pm
hepatitis C
Phamasset
PSI-7977
Idenix: Not Worth the Wait
Seeking Alpha
Thu, 03/17/11 - 11:01 am
Indenix
hepatitis C
Pharmasset
HCV
Who Will Win the Hepatitis C Market?
Seeking Alpha
Mon, 03/14/11 - 10:44 am
hepatitis C
Gilead Sciences
Merck
Bristol-Myers Squibb
Novartis
Pfizer
Vertex Pharmaceuticals
Pharmasset
Pharmasset: The Real Numbers Behind the Hype
Seeking Alpha
Fri, 03/11/11 - 11:44 am
Pharmasset
hepatitis C
[video]Stocks Under $5: Is There Value in Idenix?
TheStreet.com
Wed, 03/9/11 - 01:52 pm
Indenix
HIV
hepatitis C
Vertex drops on competitive fears
Bizjournals.com
Wed, 03/9/11 - 07:46 am
Vertex Pharmaceuticals
Pharmasset
hepatitis C
Telaprevir
Gilead Drug Combination Cut Hepatitis Virus in Study, RBC Says
Bloomberg
Tue, 03/8/11 - 07:58 am
Gilead Sciences
hepatitis C
Four Biotechs to Watch Early This Week
Seeking Alpha
Sun, 03/6/11 - 12:35 pm
Inhibitex
INX-189
hepatitis C
herpes zoster
shingles
S. aureus
ImmunoCellular Therapeutics
ICT107
glioblastoma multiforme
Jazz Pharmaceuticals
Repros Therapeutics
Vertex’s Telaprevir Reduces Hepatitis Rates in HIV Patients
Bloomberg
Thu, 03/3/11 - 07:21 am
Vertex Pharmaceuticals
HIV
hepatitis C
Telaprevir
OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
Tue, 02/22/11 - 10:24 am
OraSure
approvals
FDA
Oraquick
diagnostics
hepatitis C
Priority Review for Vertex HCV Drug
Zacks
Sat, 01/22/11 - 10:54 am
Vertex Pharmaceuticals
Telaprevir
HCV
hepatitis C
Vertex says FDA will rule on telaprevir by May 23
Yahoo/AP
Thu, 01/20/11 - 10:05 am
Telaprevir
FDA
Vertex Pharmaceuticals
JNJ
hepatitis C
Bristol-Myers, Pharmasset plan hepatitis C study
Yahoo/AP
Mon, 01/10/11 - 12:23 pm
hepatitis C
Pharmasset
Bristol-Myers Squibb

Pages